AstraZeneca Whittles Down Seroquel Case
In an increasingly bitter dispute in the multidistrict litigation over antipsychotic drug Seroquel, AstraZeneca LP asked a federal court on Tuesday to force the plaintiffs to substitute a case scheduled for...To view the full article, register now.
Already a subscriber? Click here to view full article